Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naoxuekang Dropping Pills in Hypertensive Intracerebral Hemorrhage
NCT07200921Phase 2Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Oct 2025
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naoxuekang in intraparenchymal hematoma (IPH), sponsored by Beijing Tiantan Hospital. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
naoxuekang
03
Conditions
intraparenchymal hematoma (IPH)
Beyond the preview
Go deeper on NCT07200921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07200921.